Iconic Therapeutics is using Tissue Factor biology to create new treatment for age-related macular degeneration with retinal disease in addition to cancer.
Biotech company Aura Biosciences has secured a $21 million Series B round of funding led by financing from Advent Life Sciences and both new and previous investors. The company is focused on using the money to further develop its mini-drug-delivery capsules (synthetic viruses). This technology was discovered and developed in partnership with Dr. John Schiller […]
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.